INVASIVE INTERVENTIONS IN STRUCTURAL HEART DISEASES: COMPREHENSIVE TECHNIQUES

Invasive Interventions in Structural Heart Diseases-kapak

AORTIC VALVE INTERVENTIONAL PROCEDURES: LONG-TERM OUTCOMES AND FOLLOW-UP

Orhan Karayiğit

Yozgat City Hospital, Department of Cardiology, Yozgat, Türkiye

Karayiğit O. Aortic Valve Interventional Procedures: Long-Term Outcomes and Follow-Up. In: Tanık VO, Özlek B, editors. Invasive Interventions in Structural Heart Diseases: Comprehensive Techniques. 1st ed. Ankara: Türkiye Klinikleri; 2025. p.329-338.

ABSTRACT

Transcatheter Aortic Valve Implantation (TAVI) has become an important therapeutic approach for treating aortic stenosis in recent years. Originally developed for patients with high surgical risk, TAVI is now increasingly being used in those with lower surgical risk. As the procedure becomes more commonly performed across a broader patient population, further insights will be gained regarding its potential benefits and long-term effects. This section will explore the long-term outcomes of TAVI, drawing on key clinical studies.

Keywords: Aortic stenosis; Surgical aortic valve replacement; Surgical risk; Transcatheter aortic valve implantation; Long-term outcomes

Referanslar

  1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607. [Crossref]  [PubMed]
  2. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, et al; PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366(18):1696-1704. [Crossref]  [PubMed]
  3. Kapadia SR, Tuzcu EM, Makkar RR, Svensson LG, Agarwal S, Kodali S, et al. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation. 2014;130(17):1483-1492. [Crossref]  [PubMed]
  4. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al; PARTNER trial investigators. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485-2491. [Crossref]  [PubMed]
  5. Siontis GC, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J. 2016;37(47):3503-3512. [Crossref]  [PubMed]
  6. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in highrisk patients. N Engl J Med. 2011;364(23):2187-2198. [Crossref]  [PubMed]
  7. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al; PARTNER Trial Investigators. Twoyear outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686-1695. [Crossref]  [PubMed]
  8. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al; PARTNER 1 trial investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477-2484. [Crossref]  [PubMed]
  9. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790-1798. [Crossref]  [PubMed]
  10. Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, et al. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2015;66(2):113-121. [Crossref]  [PubMed]
  11. Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, et al; CoreValve US Clinical Investigators. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016;67(22):2565-2574. [Crossref]  [PubMed]
  12. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al; PARTNER 2 Investigators. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374(17):1609-1620. [Crossref]  [PubMed]
  13. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, et al; SURTAVI Investigators. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017;376(14):1321-1331. [Crossref]  [PubMed]
  14. Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al; PARTNER 2 Investigators. Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. N Engl J Med. 2020;382(9):799-809. Published 2020 Jan 29. [Crossref]  [PubMed]
  15. Van Mieghem NM, Deeb GM, Søndergaard L, Grube E, Windecker S, Gada H, et al; SURTAVI Trial Investigators. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. JAMA Cardiol. 2022;7(10):1000-1008. [Crossref]  [PubMed]  [PMC]
  16. Forrest JK, Deeb GM, Yakubov SJ, Gada H, Mumtaz MA, Ramlawi B, et al; Evolut Low Risk Trial Investigators. 4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial. J Am Coll Cardiol. 2023;82(22):2163-2165. [Crossref]  [PubMed]
  17. Mack MJ, Leon MB, Thourani VH, Pibarot P, Hahn RT, Genereux P, et al; PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years. N Engl J Med. 2023;389(21):1949-1960. [Crossref]  [PubMed]
  18. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, et al; Evolut Low Risk Trial Investigators. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019;380(18):1706-1715. [Crossref]  [PubMed]
  19. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al; PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019;380(18):1695-1705. [Crossref]  [PubMed]
  20. Leon MB, Mack MJ, Hahn RT, Thourani VH, Makkar R, Kodali SK, et al; PARTNER 3 Investigators. Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. J Am Coll Cardiol. 2021;77(9):1149-1161. [Crossref]  [PubMed]
  21. Blankenberg S, Seiffert M, Vonthein R, Baumgartner H, Bleiziffer S, Borger MA, et al; DEDICATE-DZHK6 Trial Investigators. Transcatheter or Surgical Treatment of Aortic-Valve Stenosis. N Engl J Med. 2024;390(17):1572-1583. [Crossref]  [PubMed]
  22. Thyregod HGH, Jørgensen TH, Ihlemann N, Steinbrüchel DA, Nissen H, Kjeldsen BJ, et al. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J. 2024;45(13):1116-1124. [Crossref]  [PubMed]  [PMC]
  23. Chandrasekhar J, Hibbert B, Ruel M, Lam BK, Labinaz M, Glover C. Transfemoral vs Non-transfemoral Access for Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis. Can J Cardiol. 2015;31(12):1427-1438. [Crossref]  [PubMed]
  24. Williams M, Kodali SK, Hahn RT, Humphries KH, Nkomo VT, Cohen DJ, et al. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. 2014;63(15):1522-1528. [Crossref]  [PubMed]
  25. Saad M, Nairooz R, Pothineni NVK, Almomani A, Kovelamudi S, Sardar P, et al. Long-Term Outcomes With Transcatheter Aortic Valve Replacement in Women Compared With Men: Evidence From a Meta-Analysis. JACC Cardiovasc Interv. 2018;11(1):24-35. [Crossref]  [PubMed]
  26. Lanz J, Kim WK, Walther T, Burgdorf C, Möllmann H, Linke A, et al; SCOPE I investigators. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet. 2019;394(10209):1619-1628. [Crossref]  [PubMed]
  27. Tamburino C, Bleiziffer S, Thiele H, Scholtz S, Hildick-Smith D, Cunnington M, et al. Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial. Circulation. 2020;142(25):2431- 2442. [Crossref]  [PubMed]
  28. Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med. 2015;373(21):2015-2024. [Crossref]  [PubMed]
  29. Chakravarty T, Søndergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, et al; RESOLVE; SAVORY Investigators. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017;389(10087):2383-2392. [Crossref]  [PubMed]
  30. Ya'Qoub L, Arnautovic J, Sharkawi M, AlAasnag M, Jneid H, Elgendy IY. Antithrombotic Management for Transcatheter Aortic Valve Implantation. J Clin Med. 2023;12(24):7632. [Crossref]  [PubMed]  [PMC]
  31. Rodés-Cabau J, Masson JB, Welsh RC, Garcia Del Blanco B, Pelletier M, Webb JG, et al. Reply: Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve. JACC Cardiovasc Interv. 2017;10(15):1599- 1600. [Crossref]  [PubMed]
  32. Raheja H, Garg A, Goel S, Banerjee K, Hollander G, Shani J, et al. Comparison of single versus dual antiplatelet therapy after TAVR: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2018;92(4):783-791. [Crossref]  [PubMed]
  33. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al; American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1-76. Erratum in: J Am Coll Cardiol. 2014;64(21):e1-e76. [Crossref]  [PubMed]